Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Apr 24;9(4):1240.
doi: 10.3390/jcm9041240.

A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block

Affiliations

A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block

Chang-Hoon Koo et al. J Clin Med. .

Abstract

Sugammadex reverses the rocuronium-induced neuromuscular block by trapping the cyclopentanoperhydrophenanthrene ring of rocuronium. Dexamethasone shares the same steroidal structure with rocuronium. The purpose of this study was to evaluate the influence of dexamethasone on neuromuscular reversal of sugammadex after general anesthesia. Electronic databases were searched to identify all trials investigating the effect of dexamethasone on neuromuscular reversal of sugammadex after general anesthesia. The primary outcome was time for neuromuscular reversal, defined as the time to reach a Train-of-Four (TOF) ratio of 0.9 after sugammadex administration. The secondary outcome was the time to extubation after sugammadex administration. The mean difference (MD) and 95% CI were used for these continuous variables. Six trials were identified; a total of 329 patients were included. The analyses indicated that dexamethasone did not influence the time for neuromuscular reversal of sugammadex (MD -3.28, 95% CI -36.56 to 29.99, p = 0.847) and time to extubation (MD 25.99, 95% CI -4.32 to 56.31, p = 0.093) after general anesthesia. The results indicate that dexamethasone did not influence the neuromuscular reversal of sugammadex in patients after general anesthesia. Therefore, the dexamethasone does not appear to interfere with reversal of neuromuscular blockade with sugammadex in patients undergoing general anesthesia for elective surgery.

Keywords: dexamethasone; neuromuscular blockade; sugammadex.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram of included and excluded studies.
Figure 2
Figure 2
Time(s) to recovery of TOF ratio > 0.9. Dexamethasone vs. control.
Figure 3
Figure 3
Sensitivity analysis by excluding one trial at time(s) to recovery of TOF ratio > 0.9.
Figure 4
Figure 4
Time to extubation. Dexamethasone administration vs. control.

References

    1. Sauer M., Stahn A., Soltesz S., Noeldge-Schomburg G., Mencke T. The influence of residual neuromuscular block on the incidence of critical respiratory events. A randomised, prospective, placebo-controlled trial. Eur. J. Anaesthesiol. 2011;28:842–848. doi: 10.1097/EJA.0b013e328345cd11. - DOI - PubMed
    1. Suy K., Morias K., Cammu G., Hans P., van Duijnhoven W.G., Heeringa M., Demeyer I. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology. 2007;106:283–288. doi: 10.1097/00000542-200702000-00016. - DOI - PubMed
    1. Cross K.P., Paul R.I., Goldman R.D. Single-dose dexamethasone for mild-to-moderate asthma exacerbations: Efficacy, easy, and accepatable. Can. Fam. Physician. 2011;57:1134–1136. - PMC - PubMed
    1. Liyanage C.K., Galappatthy P., Seneviratne S.L. Corticosteroids in management of anaphylaxis; a systemic review of evidence. Eur. Ann. Allergy Clin. Immunol. 2017;49:196–207. doi: 10.23822/EurAnnACI.1764-1489.15. - DOI - PubMed
    1. De Oliveira G.S., Jr., Almeida M.D., Benzon H.T., McCarthy R.J. Perioperative single dose systemic dexamethasone for postoperative pain: A meta-analysis of randomized controlled trials. Anesthesiology. 2011;115:575–588. doi: 10.1097/ALN.0b013e31822a24c2. - DOI - PubMed

LinkOut - more resources